Suppr超能文献

COVID-19 重症及危重症患者的心血管表现。

Cardiovascular manifestations in severe and critical patients with COVID-19.

机构信息

Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China.

Department of Cardiology, The Third People's Hospital of Shenzhen, Shenzhen, China.

出版信息

Clin Cardiol. 2020 Jul;43(7):796-802. doi: 10.1002/clc.23384. Epub 2020 Jun 20.

Abstract

BACKGROUND

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could cause virulent infection leading to Corona Virus Disease 2019 (COVID-19)-related pneumonia as well as multiple organ injuries.

HYPOTHESIS

COVID-19 infection may result in cardiovascular manifestations leading to worse clinical outcome.

METHODS

Fifty four severe and critical patients with confirmed COVID-19 were enrolled. Risk factors predicting the severity of COVID-19 were analyzed.

RESULTS

Of the 54 patients (56.1 ± 13.5 years old, 66.7% male) with COVID-19, 39 were diagnosed as severe and 15 as critical cases. The occurrence of diabetes, the level of D-dimer, inflammatory and cardiac markers in critical cases were significantly higher. Troponin I (TnI) elevation occurred in 42.6% of all the severe and critical patients. Three patients experienced hypotension at admission and were all diagnosed as critical cases consequently. Hypotension was found in one severe case and seven critical cases during hospitalization. Sinus tachycardia is the most common type of arrythmia and was observed in 23 severe patients and all the critical patients. Atrioventricular block and ventricular tachycardia were observed in critical patients at end stage while bradycardia and atrial fibrillation were less common. Mild pericardial effusion was observed in one severe case and five critical cases. Three critical cases suffered new onset of heart failure. Hypotension during treatment, severe myocardial injury and pericardial effusion were independent risk factors predicting the critical status of COVID-19 infection.

CONCLUSION

This study has systemically observed the impact of COVID-19 on cardiovascular system, including myocardial injury, blood pressure, arrythmia and cardiac function in severe and critical cases. Monitoring of vital signs and cardiac function of COVID-19 patients and applying potential interventions especially for those with hypotension during treatment, severe myocardial injury or pericardial effusion, is of vital importance.

摘要

背景

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)可引起烈性感染,导致 2019 年冠状病毒病(COVID-19)相关肺炎以及多器官损伤。

假说

COVID-19 感染可能导致心血管表现,从而导致更差的临床结局。

方法

纳入 54 例确诊 COVID-19 的重症和危重症患者。分析预测 COVID-19 严重程度的危险因素。

结果

54 例患者(56.1±13.5 岁,66.7%为男性)中,39 例诊断为重症,15 例诊断为危重症。危重症患者糖尿病、D-二聚体水平、炎症和心脏标志物的发生率明显升高。肌钙蛋白 I(TnI)升高发生于所有重症和危重症患者的 42.6%。入院时 3 例患者发生低血压,均诊断为危重症。住院期间 1 例重症和 7 例危重症患者出现低血压。窦性心动过速是最常见的心律失常类型,见于 23 例重症患者和所有危重症患者。终末期危重症患者可见房室传导阻滞和室性心动过速,缓慢性心律失常和心房颤动少见。1 例重症和 5 例危重症患者可见轻度心包积液。3 例危重症患者新发心力衰竭。治疗期间低血压、严重心肌损伤和心包积液是预测 COVID-19 感染危重症状态的独立危险因素。

结论

本研究系统观察了 COVID-19 对重症和危重症患者心血管系统的影响,包括心肌损伤、血压、心律失常和心功能。监测 COVID-19 患者的生命体征和心功能,尤其是对治疗期间低血压、严重心肌损伤或心包积液的患者,应用潜在干预措施非常重要。

相似文献

1
Cardiovascular manifestations in severe and critical patients with COVID-19.
Clin Cardiol. 2020 Jul;43(7):796-802. doi: 10.1002/clc.23384. Epub 2020 Jun 20.
2
Meta-analysis of Cardiovascular Events and Related Biomarkers Comparing Survivors Versus Non-survivors in Patients With COVID-19.
Am J Cardiol. 2020 Nov 15;135:50-61. doi: 10.1016/j.amjcard.2020.08.044. Epub 2020 Sep 8.
3
Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China.
Int J Cardiol. 2020 Jul 15;311:116-121. doi: 10.1016/j.ijcard.2020.03.087. Epub 2020 Apr 8.
4
Clinical Characteristics and Prognosis of 244 Cardiovascular Patients Suffering From Coronavirus Disease in Wuhan, China.
J Am Heart Assoc. 2020 Oct 20;9(19):e016796. doi: 10.1161/JAHA.120.016796. Epub 2020 Aug 14.
5
Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19.
Nutr Metab Cardiovasc Dis. 2020 Jun 25;30(7):1061-1067. doi: 10.1016/j.numecd.2020.04.013. Epub 2020 Apr 18.
6
Effect of coronavirus infection on the human heart: A scoping review.
Eur J Prev Cardiol. 2020 Jul;27(11):1136-1148. doi: 10.1177/2047487320925965. Epub 2020 May 18.
7
Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective.
Can J Cardiol. 2020 Jul;36(7):1068-1080. doi: 10.1016/j.cjca.2020.05.018. Epub 2020 May 16.
9
Clinical Characteristics and Risk Factors of Cardiac Involvement in COVID-19.
J Am Heart Assoc. 2020 Sep 15;9(18):e016807. doi: 10.1161/JAHA.120.016807. Epub 2020 Aug 18.
10
A close-up on COVID-19 and cardiovascular diseases.
Nutr Metab Cardiovasc Dis. 2020 Jun 25;30(7):1057-1060. doi: 10.1016/j.numecd.2020.04.001. Epub 2020 Apr 8.

引用本文的文献

1
Increased interleukin-6 levels are associated with atrioventricular conduction delay in severe COVID-19 patients.
J Arrhythm. 2024 Jul 31;40(5):1137-1148. doi: 10.1002/joa3.13114. eCollection 2024 Oct.
2
The interplay between Sars-Cov-2 infection related cardiovascular diseases and depression. Common mechanisms, shared symptoms.
Am Heart J Plus. 2024 Jan 18;38:100364. doi: 10.1016/j.ahjo.2024.100364. eCollection 2024 Feb.
3
New-onset atrial fibrillation among COVID-19 patients: A narrative review.
World J Crit Care Med. 2023 Dec 9;12(5):236-247. doi: 10.5492/wjccm.v12.i5.236.
4
Cardiac complications in patients with COVID-19: a systematic review.
J Anesth Analg Crit Care. 2022 Apr 27;2(1):18. doi: 10.1186/s44158-022-00046-7.
5
Neurological implications of cardiac compromise in COVID-19.
Am J Cardiovasc Dis. 2023 Apr 15;13(2):43-51. eCollection 2023.
7
The Significance of Low Magnesium Levels in COVID-19 Patients.
Medicina (Kaunas). 2023 Jan 31;59(2):279. doi: 10.3390/medicina59020279.
9
A Case Report of Fascicular Ventricular Tachycardia in a COVID-19 Patient.
Cureus. 2022 Nov 17;14(11):e31618. doi: 10.7759/cureus.31618. eCollection 2022 Nov.

本文引用的文献

1
[Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19].
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jul 24;48(7):567-571. doi: 10.3760/cma.j.cn112148-20200225-00123.
3
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
4
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
5
A Novel Coronavirus from Patients with Pneumonia in China, 2019.
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
6
Fourth Universal Definition of Myocardial Infarction (2018).
J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264. doi: 10.1016/j.jacc.2018.08.1038. Epub 2018 Aug 25.
7
Cardiovascular complications of severe acute respiratory syndrome.
Postgrad Med J. 2006 Feb;82(964):140-4. doi: 10.1136/pgmj.2005.037515.
8
ACE2: from vasopeptidase to SARS virus receptor.
Trends Pharmacol Sci. 2004 Jun;25(6):291-4. doi: 10.1016/j.tips.2004.04.001.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验